Tirzee 7.5mg/0.5ml Pre-Filled Pen contains Tirzepatide, a novel dual GIP and GLP-1 receptor agonist. It is prescribed for the management of Type 2 Diabetes Mellitus and also supports weight loss and cardiovascular protection.

Key Uses:

• Improves blood sugar control in adults with Type 2 Diabetes

• Aids weight reduction and long-term weight management

• Reduces cardiovascular risks in diabetic patients

• Enhances overall metabolic balance

How It Works:

Tirzepatide works by stimulating both GIP and GLP-1 receptors, which increases insulin secretion, lowers glucose production, and reduces appetite. This dual action helps achieve effective diabetes control with additional weight management benefits.

Available Market Strengths:

• Tirzee 7.5mg/0.5ml Pre-Filled Pen

• Tirzee 2.5mg/0.5ml Pre-Filled Pen

• Tirzee 5mg/0.5ml Pre-Filled Pen

  Alternative Medicine:

  Patients may also consider Mounjaro 7.5mg/0.5ml Injection (Tirzepatide), another trusted brand in the same category that offers similar benefits for diabetes and weight management.